Please provide your email address to receive an email when new articles are posted on . Men prescribed long-acting testosterone undecanoate injections had a higher adherence to therapy at 1 year ...
Please provide your email address to receive an email when new articles are posted on . Testosterone undecanoate injected at 8-week intervals for men with hypogonadism may reduce fluctuations and ...
WASHINGTON--An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with ...
The approval was based on data from a phase 3 study that evaluated the efficacy and safety of Tlando in 95 adult hypogonadal male patients. The Food and Drug Administration (FDA) has approved Tlando™ ...
MIAMI -- Oral testosterone replacement therapy (TRT) seemed safe and effective in men with testosterone deficiency, according to a meta-analysis. Among nine studies that looked at changes in serum ...
NEW YORK (Reuters Health) - A new oral testosterone undecanoate formulation can restore testosterone concentrations to normal in hypogonadal men, researchers report. "Effective as other testosterone ...
The FDA has approved Kyzatrex (testosterone undecanoate) for the treatment of primary and secondary hypogonadism in adult males. The Food and Drug Administration (FDA) has approved Kyzatrex ™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results